Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

BioNTech SE - American Depositary Shares (NQ:BNTX)

103.95 -0.00 (-0.00%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,744
Open 103.95
Bid (Size) 102.29 (400)
Ask (Size) 103.00 (300)
Prev. Close 103.96
Today's Range 103.95 - 103.95
52wk Range 81.20 - 129.27
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
BioNTech Sees Higher 2025 Sales Driven By Bristol Myers Partnership
BioNTech reports a Q3 loss but boosts 2025 revenue forecast to €2.6–2.8 billion, driven by Bristol Myers collaboration and cost optimization. 
Via Benzinga
BioNTech SE (NASDAQ:BNTX) Reports Mixed Q3 2025 Results with Major Revenue Beat and Quarterly Loss
BioNTech Q3 2025: Revenue surges on a $1.5B partnership payment, but company posts a net loss. Full-year sales guidance was raised significantly. 
Via Chartmill

Performance

YTD
-9.8%
-9.8%
1 Month
-1.1%
-1.1%
3 Month
-5.5%
-5.5%
6 Month
+2.8%
+2.8%
1 Year
-4.6%
-4.6%

More News

Read More
BioNTech Announces Third Quarter 2025 Financial Results and Corporate Update
From BioNTech SE
Via GlobeNewswire
Earnings Scheduled For November 3, 2025
Via Benzinga
BioNTech to Host Innovation Series R&D Day on November 11, 2025
From BioNTech SE
Via GlobeNewswire
Healthcare Sector Navigates Volatile Waters as S&P 500 Closes: A Deep Dive into Key Market Drivers
Via MarketMinute
Topics Artificial Intelligence Economy Intellectual Property
BioNTech to Report Third Quarter 2025 Financial Results and Corporate Update on November 3, 2025
From BioNTech SE
Via GlobeNewswire
2 Unstoppable Dividend Stocks Yielding More Than 4% That Income-Seeking Investors Will Want to Buy in November and Hold Forever
Via The Motley Fool
Topics Government Intellectual Property World Trade
BioNTech Commences Public Exchange Offer for All Outstanding Shares of CureVac N.V.
From BioNTech SE
Via GlobeNewswire
Beyond The Numbers: 7 Analysts Discuss BioNTech Stock
Via Benzinga
Ionis Pharmaceuticals (NASDAQ:IONS) Ascends to Six-Year High, Fueled by Breakthrough Pipeline and Robust Sales Outlook
Via MarketMinute
Healthcare Stocks Are Rising: Here Are 2 With Even More Upside Ahead
Via The Motley Fool
Topics Government World Trade
Healthcare Sector Shines Amidst Market Turbulence, Bolstering S&P 500 Resilience
Via MarketMinute
Topics Artificial Intelligence Economy Stocks
Decoding Life's Blueprint: New Tech Maps RNA-Protein Interactions, Unlocking Disease Cures
Via MarketMinute
Topics Artificial Intelligence Derivatives
Why BioNTech Stock Jumped by Nearly 4% on Wednesday
Via The Motley Fool
Topics Artificial Intelligence Government World Trade
BioNTech to Host Second AI Day as an Edition of Its Innovation Series on October 1, 2025
From BioNTech SE
Via GlobeNewswire
Why BioNTech Stock Bumped Higher Today
Via The Motley Fool
CDC Ends Universal Covid Vaccine Recommendation; Moderna Skids
Via Investor's Business Daily
The Battle Over Covid Vaccines Hits A Fever Pitch As RFK-Picked Panel Makes Its Debut
Via Investor's Business Daily
Topics Government
Global Cell Therapy Market Size Expected to Reach $44 Billion as Demand for Regenerative Medicine Rises
Via FinancialNewsMedia
Topics Artificial Intelligence
Moderna Reports 8-Fold Jump In Antibodies With Updated Spikevax
Via Benzinga
Oracle Retreats, Fed Rate Cut Looms, and Vaccine Politics Shake Pharma Stocks
Via Chartmill
Topics Artificial Intelligence Economy
Synopsys, Chewy, And The Trade Desk Are Among Top 10 Large Cap Losers Last Week (Sep. 8- Sep. 12): Are The Others In Your Portfolio?
Via Benzinga
Topics Earnings
Why BioNTech Stock Sank by More Than 7% Today
Via The Motley Fool
Topics Death Government
Pfizer, Moderna, BioNTech Stocks Tumble After Report Of Plan To Link COVID Vaccines To Child Deaths
Via Benzinga
Topics Government

Frequently Asked Questions

Is BioNTech SE - American Depositary Shares publicly traded?
Yes, BioNTech SE - American Depositary Shares is publicly traded.
What exchange does BioNTech SE - American Depositary Shares trade on?
BioNTech SE - American Depositary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for BioNTech SE - American Depositary Shares?
The ticker symbol for BioNTech SE - American Depositary Shares is BNTX on the Nasdaq Stock Market
What is the current price of BioNTech SE - American Depositary Shares?
The current price of BioNTech SE - American Depositary Shares is 103.95
When was BioNTech SE - American Depositary Shares last traded?
The last trade of BioNTech SE - American Depositary Shares was at 11/03/25 04:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.